Stewart Appelrouth, Director at HEMISPHERX BIOPHARMA INC (HEB), bought 25,238 shares at $0.22 ($6K) on 2018-11-05, disclosed to the SEC on 2018-11-06.
Recurring purchase ($6k) by Director following this insider's established cadence. Pattern-driven, low signal.
Something here stands out, but not much.
| Filing → |
| AIM | BUY | 2024-03-18 | $30K | — | Filing → |
| AIM | BUY | 2023-01-04 | $25K | — | Filing → |
| AIM | BUY | 2021-02-25 | $25K | — | Filing → |